Non-invasive disease detection through a scan of the eye with Occuity

The UK Investor Magazine was thrilled to welcome Dan Daly, Founder & CEO of Occuity, and CCO Mark Jenkins to delve into Occuity’s eye scanning disease detection technology.

Find out more about Occuity on Republic here.

Occuity is developing handheld, non-contact devices that use the eye as a window to the body’s health.

The company’s patented optical technology already addresses glaucoma and myopia, while future products will target disease screening and, ultimately, a non-invasive glucose meter for diabetes monitoring.

Occuity enables screening of glaucoma, myopia and diabetes through optical MedTech backed by 15 patents and £4 million in grant funding. Its first product is selling globally through 19 distributors. The company has established a proven platform with a strategic pipeline of products in development.

The company has been busy forging commercial partnerships and is well placed to push forward with its growth strategy on the completion of their current fundraising round.

Cerillion growth set to accelerate this year

2

Growth slowed at AIM-quoted telecoms enterprise software provider Cerillion (LON:CER) last year, but that was due to the timing of contract wins. This year growth will accelerate because of contracts already won and there could be further wins in the coming months.

In the year to September 2025, revenues were 4% ahead at £45.4m – they were lower at the interim stage. Underlying pre-tax profit was 10% higher at £21.8m. The total dividend is 15.4p/share, up 17%. Net cash is £34.4m.

New orders were 25% higher at £47.6m. There was a contract with an existing customer worth £25.3m in total that was won at the end of the period. Including recurring maintenance and other revenues, there is around £25m of revenues already booked for this financial year.

The potential sales pipeline is at a new record level of £275m even after the recent contract wins. There is continued investment in technology, including AI.

Mergers in Cerillion’s market sector are likely to reduce competition at tenders and they are also providing opportunities to take on experienced staff from the merged entities.

Panmure Liberum forecasts 2025-26 revenues of £54m, while margins are likely to decline from their current high levels due to investment in additional sales staff. Pre-tax profit is forecast at £22.7m, rising to £24.9m next year. Cerillion tends to beat forecasts and a large contact win early enough in the year would boost the current forecast.  

The share price is 55p higher at 1410p, but it is 19% lower this year. The prospective multiple is 24 and cash will continue to increase.

FTSE 100 lifted by miners ahead of this week’s Budget

The FTSE 100 was higher on Monday as mining companies helped lift the index after BHP called time on its pursuit of Anglo American.

Traders will also find confidence in a strong rebound in US stocks on Friday, which will ease concerns about AI valuations and the outlook for interest rates.

London’s leading index was 10 points higher at the time of writing as traders eyed this week’s Budget and potential implications for UK markets.

“Equities up, gold down, bitcoin stable – this is a remarkably different picture than last week’s troubling scenes that dogged financial markets,” says Russ Mould, investment director at AJ Bell.

“It suggests investors have had time to collect their thoughts over the weekend, and to start the new week in a calmer mood. It also helps that Ukraine peace talks have dominated the news agenda, giving hope to investors and individuals around the world.”

The FTSE 100 had been higher earlier in the session, but the rally faded as the session progressed. Investors will look to US markets for the next catalyst as cash trading gets underway this afternoon.

The mining sector was the key driving force behind the gains after BHP pulled out of its pursuit of Anglo American, saying ‘it is no longer considering a combination of the two companies.’

BHP’s decision boosted the miners as investors positioned for possible M&A elsewhere in the sector.

“Miners were in vogue amid ongoing M&A activity in the sector. News that BHP has walked away from a second attempt to buy Anglo American has left investors hungry for action elsewhere,” Russ Mould said.

“Glencore was among the top risers on the FTSE as it is seen as a potential merger candidate for one of the big players, or as a buyer itself.”

Glencore rose 1.9% but it was the precious metals miners that had their noses out in front. Endeavour Mining was the top riser with a 3.7% gain, while Fresnillo rose 3.1%.

BAE Systems and Babcock were the biggest decliners, with talks to end the war in Ukraine underway. BAE Systems lost 2% and Babcock fell 1.9%.

There was a tinge of weakness in UK-centric sectors such as retailers and some financials ahead of Wednesday’s Budget.

AIM movers: Microlise hit by lower volumes and Kropz production increase

1

Kropz (LON: KRPZ) produced 87,496 tonnes of phosphate concentrate n the third quarter and sales were 28% higher at 72,408 tonnes. September was a record production month, and the mine is still in its trial production phase. The share price rebounded 27.5% to 0.65p, but it has still halved since the beginning of the year.

Trellus Health (LON: TRLS), which has developed digital technology to manage chronic conditions, has secured a $600,000 loan from 25% shareholder Icahn School of Medicine at Mount Sinai. There is no interest charge for nine months and then the annual rate is 8%. The loan is convertible into shares, but the stake cannot go above 29.9%. This will provide enough cash until late January when more cash will be required. The share price increased 23.8% to 0.65p.

Polarean Imaging (LON: POLX) has entered an exclusive distribution agreement for the Xenon MRI platform with DK Healthcare in South Korea. Polarean Imaging plans to leave AIM later this year. The share price recovered 11.8% to 0.095p.

MTI Wireless Edge (LON: MWE) reported record third quarter revenues and nine month revenues were 12% ahead at $37.8m. Operating profit was 21% higher at $4.2m. Net cash improved to $6.4m. Antenna revenues were one-fifth higher due to increasing defence demand. That offset weaker 5G demand in India. The water irrigation technology and electronics division also grew in the third quarters. The fourth quarter has stated strongly. The share price rose 9.41% to 46.5p.

GlobalData (LON: DATA) is launching a £10m share buyback and there will be further news on the timing of the move to the Main Market in January. The share price improved 9.72% to 109.5p.

FALLERS

Telematics supplier Microlise Group (LON: SAAS) says lower OEM volumes due to tariffs and the weak economy. There have also been delays in projects. There are plans to cut annualised costs by £4m. That is too late for 2025 when forecast revenues have been cut from £91.3m to £84m, while earnings have been slashed from 5.5p/share to 3.1p/share. The 2026 earnings forecast has been cut to 4.9p/share. Customer churn remains low. The share price slumped 30.1% to 97.5p.

Immupharma (LON: IMM) continues to talk with potential partners for the P140 autoimmune platform and a deal will not be secured until 2026. There is enough cash until the fourth quarter of 2026, so there is no need for a fundraising. Deals with commercial partners should provide additional finance. The share price declined 27.4% to 7.09p.

Oil and gas producer Prospex Energy (LON: PXEN) has generated revenues of £4.2m so far this year, despite the downtime at Viura and El Romeral and lower gas prices. Viura is back in production in the fourth quarter. This will enable much larger revenues in the period and generate cash for investment. The share price slipped 12.8% to 3.4p.

M&C Saatchi (LON: SAA) was hit by the US government shutdown and this has led to a downgrade of expectations for 2025. The media business has done better than expected. Group revenues have been reduced by 1% to £210m, while pre-tax profit is cut by 19% to £22.4m. There is an even greater reduction from £34m to £24.7m for 2026. Net cash of £18.5m is forecast for the end of 2025. A £5m share buyback has been launched. The share price fell 8.73% to 115p.

S4 Capital shares tumble as revenue outlook lowered

S4 Capital shares fell on Monday after the marketing group downgraded its full-year guidance following weaker-than-expected October performance.

The digital advertising group now expects 2025 like-for-like net revenue to fall just under 10%.

Shares were down 9% at the time of writing.

The revenue shortfall will hit profitability hard. Operational EBITDA is now targeted at approximately £75 million, significantly below the £81.6 million market consensus. Management blamed lower project-based revenue, continued client caution, and slower-than-anticipated conversion of new business wins.

S4’s struggles mirror those of WPP, which is also facing difficulties in the current environment.

The company has already implemented cost-cutting measures this year. However, liquidity remains stronger than forecast, with year-end net debt still expected between £100 million and £140 million.

Three AI stocks to consider as jitters subside

For those who believe in the long-term adoption of artificial intelligence, the recent sell-off of the world’s largest AI-focused names will present an opportunity.

Concerns about valuations and the circular nature of investments, partnerships, and commercial relationships have led to dramatic pullbacks in companies at the forefront of the AI arms race. 

Frothy valuations have inevitably drawn comparisons to the Dotcom boom and bust, and a growing number of analysts are calling a bubble. 

But many aren’t and still believe there are legs in the AI trade as the technology is implemented across the global economy. 

If you’re in the latter camp, these three AI stocks are well worth a look.

Nvidia

Nvidia is an obvious choice, but we’d be amiss to omit the world’s biggest AI stock from the selection. 

Recent results were initially well received, as the chipmaker beat revenue estimates and provided encouraging guidance. However, nagging doubts about supply chain constraints and whether they will be able to sell their most powerful chips to China helped fuel a reversal on the day of release.

Nvidia’s meteoric rise makes it an easy target for the naysayers. Softbank selling its entire stake hasn’t helped either. But you can’t argue against its scale and revenue generation.

The firm generated record revenue of $57.0bn in Q3, up 22% from Q2 and 62% more than a year ago. Growth was driven by data centre revenue, which rose 25% to $51bn.

The company is still experiencing soaring demand for its chips, especially for its flagship data centre Blackwell products.

“Blackwell sales are off the charts, and cloud GPUs are sold out,” said Jensen Huang, CEO of Nvidia, in their recent earnings release.

“Compute demand keeps accelerating and compounding across training and inference — each growing exponentially. We’ve entered the virtuous cycle of AI. The AI ecosystem is scaling fast — with more new foundation model makers, more AI startups, across more industries, and in more countries. AI is going everywhere, doing everything, all at once.”

The recent pullback sees Nvidia trading at just 23x forward earnings. That isn’t expensive at all.

ASML

ASML is a Netherlands-based company that manufactures the world’s most advanced lithography machines, which are essential equipment for producing semiconductors. 

Their extreme ultraviolet (EUV) lithography systems are the only tools capable of creating the tiny, densely packed transistors needed for the most powerful AI chips from companies like Nvidia, AMD, and Taiwan Semiconductor Manufacturing Company. 

Without ASML’s technology, it would be impossible to manufacture the sophisticated processors that power large language models, data centres, and AI training systems. 

No ASML would mean no chips and no AI boom.

ASML’s deep moat is likely the reason its shares are trading just 15% below recent highs. The stock certainly isn’t in bargain territory, but the dip looks like one that could be bought into.

Vistra Corp

AI data centres are expected to consume around 12% of total US power by 2030, up from 4% in 2023.

Vistra Corp is one of the largest power generators in the United States, operating a diverse portfolio of nuclear, natural gas, coal, solar, and battery storage facilities that produce approximately 41,000 megawatts of electricity. 

Imagine SSE with some fossil fuels and nuclear thrown into the mix. 

Vistra has become increasingly important to AI development because data centers require significant amounts of reliable, constant electricity to power their servers and cooling systems. 

Vistra’s nuclear plants are particularly valuable for AI infrastructure since they provide 24/7 carbon-free baseload power, making the company a key supplier for tech companies building AI data centers. 

As well as using its existing capacity to power AI data centres, Vistra is exploring co-location partnerships to build new power facilities near new data centres to secure stable power flow.

After hitting a 52-week high of $219, Vistra shares have fallen to $168. Although shares are substantially lower than recent highs, their historical valuation still looks rich at around 40x trailing earnings. Analysts, however, expect earnings to pick up significantly in the coming years with forward earnings multiples around 20x.

Director deals: Undervalued Shearwater

Shares in Cyber security services provider Shearwater Group (LON: SWG) declined after its latest results announcement. Chief executive Phil Higgins bought 10,000 shares at 48.7p each, taking his stake to 11.2%. His previous purchase was in 2023 at 64p/share. The share price subsequently fell further to 43.5p.
Jonathan Hall also bought 10,000 shares but at a share price of 48.5p. In February, he bought an initial 13,500 shares at 36p each.
Business
Shearwater provides cybersecurity and professional advisory services to a broad range of companies and governments. It sells cybersecurity software ...

Majedie Investments Investor Presentation

Watch the Majedie Investments Investor Presentation, featuring Marylebone Partners CIO and Founder Dan Higgins.

Majedie Investments is an investment trust whose purpose is to provide its shareholders with long-term capital appreciation whilst paying a regular dividend. Since its inception in 1985, the Company has sought to achieve this objective by investing for the long-term, with equities at the heart of the approach. In January 2023, the Company modified its investment policy and appointed Marylebone Partners LLP as its investment manager.

Download the slides here.

Shires Income Investor Presentation

Watch the online presentation for Shires Income, featuring Fund Manager Iain Pyle.

The Company’s investment objective is to provide shareholders with a high level of income, together with the potential for growth of both income and capital from a diversified portfolio substantially invested in UK equities but also in preference shares, convertibles and other fixed income securities.

Download the slides here.

AIM weekly movers: Bigblu Broadband leaving AIM

4

Atlantic Lithium (LON: ALL) shares improved 37.3% to 11.2p ahead of its AGM on 27 November. The main rise was on Monday when there were 11.4 million shares traded. Management believes that the mining lease for the Ewoyaa lithium project in Ghana could be granted soon.

David Nugent, who owns 16% of Genedrive (LON: GDR), has agreed the terms of a loan of up to £1m. It can be drawn down in two equal tranches. It will be secured against the company’s assets. The share price recovered 22.4% to 0.9p.

Sabien Technology (LON: SNT) says Korea-based partner City Oil Field has commissioned its first regenerated green oil production plant. The partnership is being progressed to a strategic agreement. Sabien Technology will acquire a 1.12% stake in City Oil Field for £600,000 in shares, and the UK sales agreement has been extended for ten years and will be expanded to other countries. There will also be a deal to sell products from the new plant. City Oil Field will own 15.9% of Sabien Technology. The share price increased 17.9% to 8.25p.

X-ray screening systems supplier Image Scan (LON: IGE) has secured a double-digit unit contract with its Indian partner for the ThreatScan-LS1 following a competitive tender. The share price gained 15.6% to 1.85p.

FALLERS

Bigblu Broadband (LON: BBB) is in talks with the buyer of Skymesh about the post-acquisition performance of the business and whether there is going to be any deferred consideration. Bigblu Broadband may have to compensate the buyer for debtors that have not been collected. Bigblu Broadband plans to ask for shareholder permission to leave AIM at a general meeting on 8 December. It could leave on 18 December. Management will seek to realise value form the remaining assets. The share price dived 70.3% to 5.5p.

Empyrean Energy (LON: EME) says Conrad Asia Energy has signed an agreement with PT Nations Natuna Barat for farming into the Mako gas field in the Duyung production sharing contract and the new partner will pay 100% of project development costs for a 75% non-operated participating interest in the Duyung PSC. The deal could be completed by the third quarter of 2026. Empyrean Energy is in dispute with Conrad Asia Energy about its interest in the Duyung PSC. The share price slumped 69.2% to 0.0425p.

Industrial equipment distributor HC Slingsby (LON: SLNG) is asking for shareholder approval to leave AIM. The shares are illiquid and the cost of being on AIM adds to the company’s loss, which was £237,000 in the nine months to September 2025. Net debt was £340,000. There is already support from shareholders owning 73.2% of the shares. HC Slingsby transferred from the Main Market to AIM on 24 May 2005. It has been on the London Stock Exchange for many decades. The cancellation could be on 23 December. No matched bargain facility is planned. The share price dipped 52% to 60p.

Defence consultancy RC Fornax (LON: RCFX) raised £2.25m in a placing at 6p/share and raised £70,000 out of the £500,000 retail offer. The cash will fund development of the Procure X Marketplace to connect small companies with defence buyers and provide working capital. Directors and management are investing £156,800 in new shares. This includes Paul Reeves and Daniel Clark who raised £1m in the flotation back in February, when the company raised £5.2m at 32.5p/share. Cavendish has increased its 2025-26 forecast loss to £2m and expects a lower loss next year. The share price slid 39.5p to 5.9p.